PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New molecule fights oxidative stress; May lead to therapies for cancer and Alzheimer's

New molecule fights oxidative stress; May lead to therapies for cancer and Alzheimer's
2014-10-01
(Press-News.org) COLUMBIA, Mo. – Breathing oxygen helps the body create energy for its cells. As a result of the breathing process, reactive molecules called "free radicals" are produced that often cause damage to proteins and genes found in cells. This damage is known as oxidative stress. Free radicals also have been linked to cancer, Alzheimer's and Parkinson's disease. Now, investigators at the University of Missouri have discovered a molecule that treats oxidative stress.

"Oxidative stress can cause damage to the building blocks of a cell, resulting in excessive cell proliferation, in the case of cancer or cell death, in the case of neurodegenerative diseases like Parkinson's," said Mark Hannink, a professor in the Department of Biochemistry and an investigator at the Bond Life Sciences Center at MU. "Finding the right balance is like walking a tightrope; our work has focused on finding ways to keep oxidative stress at bay."

Hannink partnered with High Point Pharmaceuticals LLC, a North Carolina-based firm, to find the right combinations of molecules to create an effective drug that fights free radicals. Using tools developed in his lab, Hannink and Kim Jasmer, a graduate student in Hannink's lab, analyzed a group of molecules developed by the pharmaceutical company that could be good candidates for treating oxidative stress. They identified a particular compound, known as HPP-4382 that has been proven effective in fighting oxidative stress and could eventually be developed into a drug. The molecule has been patented by High Point.

"Kim developed the research tools needed to identify the right molecular candidates making the research more effective and efficient," Hannink said. "We found the right molecule that corrects the imbalance of oxidative stress and could one day have wide applicability. Because of this study, we have a better understanding of what these compounds are doing to counteract oxidative stress.

The work adds to a pipeline of molecular clinical and pre-clinical drug candidates for the treatment of oxidative stress and serves as a good starting point for researchers to find similar compounds, Hannink said.

The early-stage results of this research are promising. If additional studies, including animal studies, are successful within the next few years, these compounds may be tested in human clinical trials with the hope of developing new treatments for diseases that are characterized by the over-production of free radicals and oxidative stress.

INFORMATION:

The research, "Induction of Heme Oxygenase I (HMOX1) by HPP-4382: A Novel Modulator of Bach1 Activity" was published in PLOS One with funding from High Point Pharmaceuticals.

Editor's Note: For a longer version of this story, please visit: http://decodingscience.missouri.edu/2014/10/the-search-for-oxidative-stress-treatment-continues/


[Attachments] See images for this press release:
New molecule fights oxidative stress; May lead to therapies for cancer and Alzheimer's

ELSE PRESS RELEASES FROM THIS DATE:

Decreased ability to identify odors can predict death

Decreased ability to identify odors can predict death
2014-10-01
For older adults, being unable to identify scents is a strong predictor of death within five years, according to a study published October 1, 2014, in the journal PLOS ONE. Thirty-nine percent of study subjects who failed a simple smelling test died during that period, compared to 19 percent of those with moderate smell loss and just 10 percent of those with a healthy sense of smell. The hazards of smell loss were "strikingly robust," the researchers note, above and beyond most chronic diseases. Olfactory dysfunction was better at predicting mortality than a diagnosis ...

AAO-HNSF clinical practice guideline: Tinnitus

2014-10-01
ALEXANDRIA, VA — The American Academy of Otolaryngology—Head and Neck Surgery Foundation has released the first ever mutli-disciplinary, evidence-based clinical practice guideline to improve the diagnosis and management of tinnitus, the perception of sound—often ringing—without an external sound source. The guideline was published today in the journal Otolaryngology–Head and Neck Surgery. "Tinnitus affects 10-15% of adults in the United States. It is the most common service-related disability among our military veterans. Yet despite its prevalence and effect on quality ...

Decreased ability to identify odors may predict 5-year mortality

2014-10-01
For older adults, being unable to identify scents may be a predictor of mortality within five years, according to a study published October 1, 2014, in the journal PLOS ONE by Jayant Pinto from The University of Chicago and colleagues. The study was part of the National Social Life, Health and Aging Project (NSHAP), the first in-home study of social relationships and health in a large, nationally representative sample of men and women ages 57 to 85. Researchers first surveyed 3,000 participants in 2005-06, assessing their ability to identify five distinct common odors, ...

Drug treats inherited form of intellectual disability in mice

Drug treats inherited form of intellectual disability in mice
2014-10-01
Studying mice with a genetic change similar to what is found in Kabuki syndrome, a inherited disease of humans, Johns Hopkins researchers report they have used an anticancer drug to "open up" DNA and improve mental function. Along with a potential treatment for the intellectual disability seen in Kabuki syndrome, the study's findings also suggest a new way of thinking about a category of genetic diseases known as Mendelian disorders of the epigenetic machinery, the researchers say. In these disorders, a genetic mutation causes errors in the way proteins and chemicals ...

Study finds potential new target to treat asthma attacks brought on by colds

2014-10-01
Researchers have identified a molecular mechanism that could explain why the common cold can bring on life-threatening asthma attacks. Published today in Science Translational Medicine, the findings indicate this may be a potential target for new drugs that could be more effective than existing treatments. Viruses that infect the airways are the most common cause of asthma attacks, accounting for 80-90 per cent of cases. The great majority of these are rhinoviruses, which are the predominant cause of the common cold. Although illnesses caused by rhinoviruses are ...

Stem cell discovery could lead to better treatments for blindness

2014-10-01
Scientists at the University of Southampton have discovered that a region on the front surface of the eye harbours special stem cells that could treat blinding eye conditions. This part of the eye is called the 'corneal limbus' and is a narrow gap lying between the transparent cornea and white sclera. The research, published in PLOS ONE, showed that stem cells can be cultured from the corneal limbus in vitro. Under the correct culture conditions, these cells could be directed to behave like the cells needed to see light - photoreceptor cells. The loss of photoreceptors ...

Predictor of tissue injury in kidney transplant recipients found

2014-10-01
Researchers at UC San Francisco and Rush University Medical Center, Chicago, may have found a predictor for a disorder affecting kidney transplant recipients that can accelerate organ failure, a discovery that eventually could allow for customized therapies and improved patient selection for transplant. The study of focal segmental glomerulosclerosis (FSGS), a devastating form of kidney disease, is in the Oct. 1 issue of Science Translational Medicine. Research was conducted by an international study team, with Necker Hospital in Paris and UCSF joint lead authors and ...

Researchers find promise in new treatments for GBM

2014-10-01
(Boston) — Glioblastma multiforme (GBM) is one of the most lethal primary brain tumors, with median survival for these patients only slightly over one year. Researchers at Boston University School of Medicine (BUSM), in collaboration with researchers from the City of Hope, are looking toward novel therapeutic strategies for the treatment of GBM in the form of targeted therapies against a unique receptor, the interleukin-13 receptor α chain variant 2 (IL13Rα2). In a review paper published in the October issue of Neuro-Oncology, the researchers discuss various ...

Team advances understanding of the Greenland Ice Sheet's meltwater channels

Team advances understanding of the Greenland Ice Sheets meltwater channels
2014-10-01
An international research team's field work, drilling and measuring melt rates and ice sheet movement in Greenland is showing that things are, in fact, more complicated than we thought. "Although the Greenland Ice Sheet initially speeds up each summer in its slow-motion race to the sea, the network of meltwater channels beneath the sheet is not necessarily forming the slushy racetrack that had been previously considered," said Matthew Hoffman, a Los Alamos National Laboratory scientist on the project. A high-profile paper appearing in Nature this week notes that observations ...

NASA sees intensifying typhoon Phanfone heading toward Japan

NASA sees intensifying typhoon Phanfone heading toward Japan
2014-10-01
VIDEO: NASA's TRMM satellite saw Phanfone was producing rainfall over a very large area on Oct. 1. Some storms in these bands were dropping rain at a rate of over 76... Click here for more information. An intensifying typhoon called Phanfone that originated east of Guam on September 28, 2014 is headed toward southern Japan. The TRMM satellite crossed above Typhoon Phanfone on October 1, 2014 at 1039 UTC and gathered data about rainfall rates occurring in the storm. TRMM, ...

LAST 30 PRESS RELEASES:

Global cervical cancer vaccine roll-out shows it to be very effective in reducing cervical cancer and other HPV-related disease, but huge variations between countries in coverage

Negativity about vaccines surged on Twitter after COVID-19 jabs become available

Global measles cases almost double in a year

Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen

Personalised “cocktails” of antibiotics, probiotics and prebiotics hold great promise in treating a common form of irritable bowel syndrome, pilot study finds

Experts developing immune-enhancing therapies to target tuberculosis

Making transfusion-transmitted malaria in Europe a thing of the past

Experts developing way to harness Nobel Prize winning CRISPR technology to deal with antimicrobial resistance (AMR)

CRISPR is promising to tackle antimicrobial resistance, but remember bacteria can fight back

Ancient Maya blessed their ballcourts

Curran named Fellow of SAE, ASME

Computer scientists unveil novel attacks on cybersecurity

Florida International University graduate student selected for inaugural IDEA2 public policy fellowship

Gene linked to epilepsy, autism decoded in new study

OHSU study finds big jump in addiction treatment at community health clinics

Location, location, location

Getting dynamic information from static snapshots

Food insecurity is significant among inhabitants of the region affected by the Belo Monte dam in Brazil

The Society of Thoracic Surgeons launches new valve surgery risk calculators

Component of keto diet plus immunotherapy may reduce prostate cancer

New circuit boards can be repeatedly recycled

Blood test finds knee osteoarthritis up to eight years before it appears on x-rays

April research news from the Ecological Society of America

Antimicrobial resistance crisis: “Antibiotics are not magic bullets”

Florida dolphin found with highly pathogenic avian flu: Report

Barcodes expand range of high-resolution sensor

DOE Under Secretary for Science and Innovation visits Jefferson Lab

Research expo highlights student and faculty creativity

Imaging technique shows new details of peptide structures

MD Anderson and RUSH unveil RUSH MD Anderson Cancer Center

[Press-News.org] New molecule fights oxidative stress; May lead to therapies for cancer and Alzheimer's